Orthostatic Hypotension: What to Do When First-Line Treatment Has Not Worked

This protocol addresses patients with orthostatic hypotension who have already undergone structured first-line management — including patient education, lifestyle and hydration measures, dietary salt optimisation, review and modification of hypotensive or vasoactive medications, physical counter-pressure manoeuvres, compression garments, and head-up tilt sleeping — but who continue to experience symptoms without adequate blood-pressure response.

Why escalation is triggered

First-line general measures failed to reach the defined goals: improvement of orthostatic symptoms and a rise in standing blood pressure of 10–15 mmHg. When these targets are not achieved, a further pharmacological step is indicated.

The next step adds a pharmacological agent — an oral alpha-agonist — to the existing first-line programme. The full protocol specifies the selection considerations and clinical details; only part of the approach is outlined here.

Treatment goal: an increase in blood pressure in both the supine and upright posture, and amelioration of orthostatic symptoms.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehy037

The alpha-agonist midodrine is a useful addition to first-line treatment in patients with chronic autonomic failure.
Midodrine (2.5–10 mg t.i.d) was shown to be effective in three randomized placebo-controlled trials.
Midodrine should be considered if symptoms persist.
There is no doubt that midodrine increases BP both in the supine and upright posture, and ameliorates the symptoms of OH.

View source ↗